XML 82 R63.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stock-based Compensation - Additional Information (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
Oct. 30, 2013
shares
Dec. 31, 2015
USD ($)
plan
$ / shares
shares
Dec. 31, 2014
USD ($)
$ / shares
Dec. 31, 2013
USD ($)
$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Options outstanding, weighted average remaining contractual life   7 years 11 months 27 days    
Number of equity compensation plans | plan   2    
Stock-based awards, shares granted | shares   1,328,400    
Weighted average grant date fair value (in dollars per share) | $ / shares   $ 24.83 $ 20.83 $ 3.11
Aggregate intrinsic value of options exercised | $   $ 4,300 $ 10,500 $ 9
Estimated fair value of common stock | $ / shares   $ 24.35    
2005 Aerie pharmaceutical stock plan        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Unrecognized compensation expense | $   $ 28,200    
Compensation cost, weighted average recognition period   2 years 7 months 10 days    
Options outstanding, weighted average remaining contractual life   7 years 11 months 15 days    
Stock-based awards, shares granted | shares 0      
2013 equity plan        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Equity awards | shares   5,729,068    
Minimum | 2005 Aerie pharmaceutical stock plan        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based awards, expiration period   1 year    
Maximum | 2005 Aerie pharmaceutical stock plan        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based awards, expiration period   4 years    
Restricted stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Compensation cost, weighted average recognition period   2 years 11 months    
Unrecognized compensation expense | $   $ 1,700